跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Topotecan/vincristine
首页
药物
Topotecan/vincristine
Topotecan/vincristine
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds and compositions for the treatment of cancer
US 9114118 B2
申请人: GAGNON LYNE
优先权: 2010
US
WO
5 件公开
BONE MORPHOGENETIC PROTEIN PATHWAY ACTIVATION, COMPOSITIONS FOR OSSIFICATION, AND METHODS RELATED THERETO
US 2014248372 A1
申请人: BODEN SCOTT D
优先权: 2012
US
5 件公开
Alkyne-, azide- and triazole-containing flavonoids as modulators for multidrug resistance in cancers
US 9611256 B2
申请人: UNIV HONG KONG POLYTECHNIC
优先权: 2013
US
3 件公开
Non-aqueous chemotherapeutic suspensions for oral dosage
US 12303504 B2
申请人: ONCOSOL LTD
优先权: 2018
CN
US
2 件公开
Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
US 2002019343 A1
申请人: KRATZ FELIX
优先权: 2001
US
2 件公开
Polymer nanoparticles for loading alkaline antitumor drugs
CN 102697735 A
申请人: AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIV MED SCHOOL
优先权: 2012
CN
TREATING PEDIATRIC CANCERS WITH HYDROXYUREAMETHYL ACYLFULVENE
WO 2026064751 A1
申请人: LANTERN PHARMA INC
优先权: 2024
WO
药物
反馈